Literature DB >> 17561110

Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.

Anna Ljunggren1, Izabela Redzynia, Marcia Alvarez-Fernandez, Magnus Abrahamson, John S Mort, Joanne C Krupa, Mariusz Jaskolski, Grzegorz Bujacz.   

Abstract

Chagasin is a protein produced by Trypanosoma cruzi, the parasite that causes Chagas' disease. This small protein belongs to a recently defined family of cysteine protease inhibitors. Although resembling well-known inhibitors like the cystatins in size (110 amino acid residues) and function (they all inhibit papain-like (C1 family) proteases), it has a unique amino acid sequence and structure. We have crystallized and solved the structure of chagasin in complex with the host cysteine protease, cathepsin L, at 1.75 A resolution. An inhibitory wedge composed of three loops (L2, L4, and L6) forms a number of contacts responsible for high-affinity binding (K(i), 39 pM) to the enzyme. All three loops interact with the catalytic groove, with the central loop L2 inserted directly into the catalytic center. Loops L4 and L6 embrace the enzyme molecule from both sides and exhibit distinctly different patterns of protein-protein recognition. Comparison with a 1.7 A structure of uncomplexed chagasin, also determined in this study, demonstrates that a conformational change of the first binding loop (L4) allows extended binding to the non-primed substrate pockets of the enzyme active site cleft, thereby providing a substantial part of the inhibitory surface. The mode of chagasin binding is generally similar, albeit distinctly different in detail, when compared to those displayed by cystatins and the cysteine protease inhibitory p41 fragment of the invariant chain. The chagasin-cathepsin L complex structure provides details of how the parasite protein inhibits a host enzyme of possible importance in host defense. The high level of structural and functional similarity between cathepsin L and the T. cruzi enzyme cruzipain gives clues to how the cysteine protease activity of the parasite can be targeted. This information will aid in the development of synthetic inhibitors for use as potential drugs for the treatment of Chagas disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561110     DOI: 10.1016/j.jmb.2007.05.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Versatile loops in mycocypins inhibit three protease families.

Authors:  Miha Renko; Jerica Sabotic; Marko Mihelic; Joze Brzin; Janko Kos; Dusan Turk
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

2.  The macromolecular complex of ICP and falcipain-2 from Plasmodium: preparation, crystallization and preliminary X-ray diffraction analysis.

Authors:  Guido Hansen; Britta Schwarzloh; Annika Rennenberg; Volker T Heussler; Rolf Hilgenfeld
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

3.  Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form.

Authors:  Joyce J W Wong; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

Review 4.  Prokaryote-derived protein inhibitors of peptidases: A sketchy occurrence and mostly unknown function.

Authors:  Tomasz Kantyka; Neil D Rawlings; Jan Potempa
Journal:  Biochimie       Date:  2010-06-14       Impact factor: 4.079

5.  Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl.

Authors:  Eric T Larson; Fabiola Parussini; My-Hang Huynh; Jonathan D Giebel; Angela M Kelley; Li Zhang; Matthew Bogyo; Ethan A Merritt; Vern B Carruthers
Journal:  J Biol Chem       Date:  2009-07-13       Impact factor: 5.157

6.  The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin.

Authors:  Robert Huang; Xuchu Que; Ken Hirata; Linda S Brinen; Ji Hyun Lee; Elizabeth Hansell; Juan Engel; Mohammed Sajid; Sharon Reed
Journal:  Mol Biochem Parasitol       Date:  2008-12-06       Impact factor: 1.759

7.  Transcriptomic alterations in Trypanosoma cruzi-infected cardiac myocytes.

Authors:  Regina Coeli Dos Santos Goldenberg; Dumitru A Iacobas; Sanda Iacobas; Leonardo Lima Rocha; Fabio da Silva de Azevedo Fortes; Leandro Vairo; Fnu Nagajyothi; Antonio Carlos Campos de Carvalho; Herbert B Tanowitz; David C Spray
Journal:  Microbes Infect       Date:  2009-09-01       Impact factor: 2.700

8.  Structural basis for the recognition and cleavage of histone H3 by cathepsin L.

Authors:  Melanie A Adams-Cioaba; Joanne C Krupa; Chao Xu; John S Mort; Jinrong Min
Journal:  Nat Commun       Date:  2011-02-15       Impact factor: 14.919

9.  Solution structure of a phytocystatin from Ananas comosus and its molecular interaction with papain.

Authors:  Deli Irene; Tse-Yu Chung; Bo-Jiun Chen; Ting-Hang Liu; Feng-Yin Li; Jason T C Tzen; Cheng-I Wang; Chia-Lin Chyan
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

10.  The role of conserved residues of chagasin in the inhibition of cysteine peptidases.

Authors:  Flavia C G dos Reis; Brian O Smith; Camila C Santos; Tatiana F R Costa; Julio Scharfstein; Graham H Coombs; Jeremy C Mottram; Ana Paula C A Lima
Journal:  FEBS Lett       Date:  2008-01-15       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.